Clinical Trial Update: Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension [Phase 2, Phase 3]

View source ↗

Summary

This update reports the results of a Phase 2/Phase 3 study evaluating the safety and efficacy of imatinib mesylate in patients with pulmonary arterial hypertens…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Pulmonary Arterial Hypertension | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-03-23